Interaction of digitalis and spironolactone with human sex steroid receptors

Journal of Clinical Endocrinology and Metabolism

Volumn 46, Issue 2, 1978, Pages 338-344

  Rifka, Safa M ^a   Pita, Julio C ^a   Vigersky, Robert A ^a   Wilson, Yvonne A ^a   Lynn Loriaux, D ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTANOLONE H 3; CYTOSOL RECEPTOR; DEXAMETHASONE; DIETHYLSTILBESTROL; DIGITALIS; DIGITOXIN; DIGOXIN; DRUG RECEPTOR; ESTRADIOL; ESTRADIOL H 3; ESTRIOL; ESTROGEN RECEPTOR; ESTRONE; HYDROCORTISONE; PROGESTERONE; RADIOISOTOPE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; DRUG INTERACTION; ENDOCRINE SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PREPUCE; PROSTATE; UTERUS;

BINDING, COMPETITIVE; DIGITOXIN; ESTRADIOL; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MENOPAUSE; PENIS; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, STEROID; SEX HORMONE-BINDING GLOBULIN; SPIRONOLACTONE; UTERUS;

EID: 0018130825     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-46-2-338     Document Type: Article

References (26)

1. NAVAB, A., L. KOSS, Y. S. LADUE, Digitalis may affect pap smear interpretation, JAMA 194: 33, 1965.
2. BURKHARDT, D., C. A. VERA, and J. S. LADUE, Effect of digitalis on urinary pituitary gonadotrophin excretion, Ann Intern Med 68: 1069, 1968.
3. STOFFER, S. S., K. M. HYNES, N. S. JIANG, and R. RYAN, Digoxin and Abnormal serum hormone level, JAMA 225: 1643, 1973.
4. VONCAPELLER, D., G. COPELAND, and T. N. STERN, Digitalis intoxication: A clinical report of 148 cases, Ann Intern Med 50: 869, 1959.
5. CALOV, W. L., and H. M. WHYTE, Edema and mammary hypertrophy: A toxic effect of digitalis leaf, Med J Aust 41: 556, 1954.
6. BLOCH, K., Zur pathogenes der mamma-hypertrophie bei-der digitalis-applikations, Z Kreislaufforsch 50: 591, 1961.
7. LEWINN, E. G., Gynecomastia during digitalis therapy, N Engl J Med 248: 316, 1953.
8. RODSTEIN, M., Gynecomastia an unusual manifestation of digitalis toxicity, GP 26: 95, 1962.
9. SCHULTHEISS, M., Gynaekomastia als digitalis nebenwirband, Hippokrates 33: 806, 1962.
10. CLARK, E., Spironolactone therapy and gynecomastia, JAMA 193: 157, 1965.
11. LEVITT, J. I., Spironolactone therapy and amenorrhea, JAMA 211: 2014, 1970.
12. RIFKA, S. M., J. C. PITA, JR., and D. L. LORIAUX, Mechanism of interaction of digitalis with estradiol binding sites in rat uteri, Endocrinology 99: 1091, 1976.
13. PITA, Jr., J. C, M. E. LIPPMANN, E. B. THOMPSON, and D. L. LORIAUX, Interaction of spironolactone and digitalis with the 5a-dihydrotestosterone (DHT) receptor of rat ventral prostate, Endocrinology 97: 1521, 1975.
14. BASINGER, G. T., and R. F. GITTIS, Antiandrogenic effects of spironolactone in rats, J Urol 111: 77, 1974.
15. STEELMAN, S. L., J. R. BROOKS, E. R. MORGAN, and D. J. PATANELLI, Antiandrogenic activity of spironolactone, Steroids 14: 449, 1969.
16. BONNE, C, and J. P. RAYNAUD, Mode of spironolactone antiandrogenic action: Inhibition of androstanolone binding to rat prostate androgen receptor, Mol Cell Endocrinol 2: 59, 1974.
17. CORVOL, P., A. MICHAUD, J. MENARD, M. FREIFELD, and J. MAHOUDEAU, Antiandrogenic effects of spironolactone: Mechanism of action, Endocrinology 97: 52, 1975.
18. CHAMNESS, G. C, K. HUFF, and W. L. MCGUIRE, Protamine precipitated estrogen receptor: A solid phase ligand exchange assay, Steroids 25: 627, 1975.
19. DEMEYTS, P. J., In Methods in Receptor Research, Blecher, M. (ed.), Marcell Dekker, New York, 1976.
20. WEBB, J. L., Enzyme and Metabolic Inhibitors, vol. 1, p. 149. Academic Press, New York, 1963.
21. CORVOL, P. L., A. GRUMBACH, D. RODBARD, and C. W. BARDIN, Physical properties and binding capacity of testosterone-estradiol-binding globulin in human plasma, determined by polyacrylamide gel electrophoresis, J Biol Chem 246: 3435, 1971.
22. RITZEN, E. M., F. S. FRENCH, S. C. WEDDINGTON, S. N. NAYFEH, and V. HANSSON, Steroid binding in polyacrylamide gel. Quantitation of steady-state conditions, J Biol Chem 249: 6597, 1974.
23. BRITSCH, C. J., and H. A. AZAR, Estrogen effect in exfoliated vaginal cells following treatment with digitalis, Am J Obstet Gynecol 85: 989, 1963.
24. DOHERTY, J. E., Digitalis glycosides: pharmacokinetics and their clinical implications, Ann Intern Med 79: 229, 1973.
25. MENARD, R. H., B. STRIPP, and J. R. GILLETTE, Spironolactone and testicular cytochrome P-450: Decreased testosterone formation in several species and changes in hepatic drug metabolism, Endocrinology 94: 1628, 1974.
26. TAYLOR, A. A., J. R. MITCHELL, D. E. ROLLINS, W. R. SNODGRASS, and F. C. BARTTER, Effect of spironolactone on adrenal and gonadal steroids in man, Clin Res 24: 279A, 1976.